Table 5 Comparison of test and placebo groups in terms of patient satisfaction
| Â | Univariable | Multivariable | ||||
|---|---|---|---|---|---|---|
No | Yes | OR (95% CI) | P-value | OR (95% CI) | P-value | |
Group | ||||||
 Active | 3 (9.1%) | 30 (90.9%) | 9.38 (2.36,37.3) | 0.001 | 9.83 (2.40,40.27) | 0.001 |
 Placebo | 15 (48.4%) | 16 (51.6%) | Reference | Reference | ||
Sex | ||||||
 Female | 11 (25.6%) | 32 (74.4%) | 1.46 (0.47,4.53) | 0.518 | 1.77 (0.43,7.33) | 0.430 |
 Male | 7 (33.3%) | 14 (66.7%) | Reference | Reference | ||
Marital Status | ||||||
 Single | 7 (29.2%) | 17 (70.8%) | Reference | 0.886 | Reference | 0.547 |
 Married | 11 (27.5%) | 29 (72.5%) | 1.09 (0.35,3.33) | 1.75 (0.28,10.88) | ||
Duration of Migraine | ||||||
 ≤2 years | 10 (27.8%) | 26 (72.2%) | 1.04 (0.35,3.12) | 0.944 | 1.10 (0.27,4.46) | 0.891 |
 > 2 years | 8 (28.6%) | 20 (71.4%) | Reference | Reference | ||
Age (mean ± SD) | 37.39 ± 9.17 | 36.04 ± 9.48 | 0.98 (0.93,1.04) | 0.602 | 0.96 (0.86,1.06) | 0.399 |
BMI (mean ± SD) | 24.06 ± 2.85 | 23.94 ± 3.14 | 0.99 (0.82,1.18) | 0.987 | 1.04 (0.77,1.40) | 0.811 |